Category:
Anti-tumor Preparations
Standard:
N;
Recombinant human thrombopoietin injection is a biopharmaceutical produced via recombinant DNA technology in mammalian cell lines. It mimics endogenous TPO to stimulate megakaryocyte proliferation and platelet production.